This inventor holds 1 USPTO granted patent and 6 published patent applications and 3 EPO patents. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Roman Christian Messerschmid: Innovator in Glycine Transport Inhibition
Introduction
Roman Christian Messerschmid is a notable inventor based in Wiesbaden, Germany. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of glycine transport inhibitors. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical research.
Latest Patents
Messerschmid holds a patent for a process of reworking a crystalline form of a glycine transport inhibitor. The invention describes a process for reworking a crystallization product that involves drying and homogenization. The crystallization product is identified as crystalline [5-(methylsulfonyl)-2-{[(2R)-1,1,1-trifluoropropan-2-yl]oxy}phenyl]{(1R,5R)-1-[5-(trifluoromethyl)-1,2-oxazol-3-yl]-3-azabicyclo[3.1.0]hex-3-yl}methanone. The product is dried in a tray dryer or in a pan dryer and subsequently homogenized. This innovative process enhances the efficiency and effectiveness of the glycine transport inhibitor.
Career Highlights
Messerschmid is currently associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role at the company allows him to contribute to groundbreaking research and development in the pharmaceutical industry. His work is characterized by a commitment to improving therapeutic options for patients.
Collaborations
Throughout his career, Messerschmid has collaborated with talented professionals in the field. Notable coworkers include Julia Regina Grimm and Katrin Baer, who have worked alongside him in various projects. These collaborations have fostered an environment of innovation and creativity, leading to significant advancements in their respective areas of expertise.
Conclusion
Roman Christian Messerschmid is a distinguished inventor whose work in glycine transport inhibition has made a meaningful impact in the pharmaceutical industry. His patent reflects his innovative spirit and dedication to improving medical treatments. Through his career at Boehringer Ingelheim International GmbH, he continues to push the boundaries of scientific research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile